Company Filing History:
Years Active: 1979-1980
Title: Robert Fontanges: Innovator in Viral Glycoprotein Production
Introduction
Robert Fontanges, based in Lyon, France, is a notable inventor recognized for his contributions to the field of virology. With a focus on glycoprotein production from viral sources, his innovative processes aim to enhance therapeutic strategies for influenza prevention and treatment.
Latest Patents
Fontanges holds two significant patents:
1. **Process for the Preparation of Hemagglutinin from Viral Sources**
This patent details a method for producing hemagglutinin in a substantially pure form from the cultures of Myxovirus Influenzae. The glycoprotein is essential for developing treatments to combat the flu.
2. **Process for the Preparation of Neuraminidase from Viral Sources**
Similar to his previous patent, this invention outlines the process for obtaining neuraminidase, another glycoprotein from Myxovirus Influenzae cultures, which shares a crucial role in flu prevention and therapy.
Career Highlights
Currently, Robert Fontanges is affiliated with Science Union Et Cie, a leading research entity focused on medical advancements. His innovative work in viral glycoprotein production has positioned him as a key figure in the fight against influenza-related diseases.
Collaborations
Throughout his career, Fontanges has engaged in various collaborations within the scientific community, emphasizing partnerships that enhance research capabilities and accelerate the development of effective treatments for viral infections.
Conclusion
Robert Fontanges exemplifies the spirit of innovation in the medical field, with his cutting-edge patents contributing significantly to the understanding and management of influenza. His work continues to have a profound impact on therapeutic research and public health initiatives.